Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease
PaperCitations, authors & open-access status
Ustekinumab dose escalation improves clinical responses in refractory Crohn’s disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 38 citations, 2020 year and gold oa status.
38
Citations
2020
Year
gold
OA Status